Google Cloud and Deloitte’s partnership reaches the AI Biotech sector
The healthcare industry is struggling to keep up with advancements in technology. Creating more personalized care requires improved data management, while diagnosing patients more efficiently calls for artificial intelligence. Google Cloud and Deloitte announced on 4/10/2019 that they are expanding their partnership to bring solutions to the life sciences and healthcare industries. With the goal of helping organizations “bring treatments to patients faster, enhance patient care, accelerate biomedical research, and improve operations,” Google Cloud‘s Contact Center AI solution and clinical data warehousing (including its Cloud Healthcare API), and Genomics and Imaging solutions will be combined with Deloitte‘s industry expertise to support healthcare organizations and life sciences companies.

Related Posts
April 15, 2021
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Activity,AI Biotech / Diagnostics: Neurology
April 8, 2021
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
April 1, 2021
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Neurology


